IMMUNEONCO-B (01541) announced that all conditions precedent to the placement agreement have been satisfied, and the delivery has been executed according to the terms and conditions of the placement agreement on October 16, 2025. As per the terms of the placement agreement, the placing agent has successfully placed a total of 24.2 million placement shares at a price of HK$14.50 per share to no fewer than six placees. This constitutes approximately 5.94% of the company’s issued share capital immediately prior to the delivery and about 6.11% of the total issued H shares. Following the issuance of the placement shares, it will represent approximately 5.61% of the enlarged issued share capital and about 5.76% of the total issued H shares of the company.